Elevated Tacrolimus Levels at Time of Diagnosis of COVID-19 Compared to Baseline Among Hospitalized Organ Transplant Recipients.
Krista MecadonAnna HardestyKendra VieiraRalph RogersBasma MerhiAdena J OsbandGeorge Bayliss MdReginald GohhPaul MorrisseyDimitrios FarmakiotisPublished in: The Annals of pharmacotherapy (2022)
Tacrolimus trough levels were elevated in most OTRs with COVID-19 at the time of hospital admission, compared to baseline. Potential mechanisms are diarrhea and hepatic involvement in COVID-19. In OTRs with COVID-19, including outpatients, immunosuppressant drug levels should be closely followed; management of immunosuppression should be individualized.